scleroderma
Very low frequency (specialist/medical term)Technical/medical
Definition
Meaning
A chronic autoimmune disease characterized by hardening and tightening of the skin and connective tissues.
It is a group of rare diseases that involve the abnormal growth of connective tissue, which supports the skin and internal organs. In more severe systemic forms, it can also affect blood vessels, muscles, and internal organs such as the heart, lungs, and digestive system.
Linguistics
Semantic Notes
The term is used almost exclusively within medical contexts. It refers to a specific pathological condition, not a symptom. It is a countable noun when referring to types (e.g., localised scleroderma) and an uncountable/mass noun when referring to the condition in general.
Dialectal Variation
British vs American Usage
Differences
No significant lexical or spelling differences. Pronunciation differs slightly (see IPA).
Connotations
Identical clinical and pathological connotations in both varieties.
Frequency
Equally rare in both varieties, confined to medical professionals, patients, and related literature.
Vocabulary
Collocations
Grammar
Valency Patterns
[Patient] was diagnosed with scleroderma.Scleroderma affects [organ/system].The main symptom of scleroderma is [symptom].Vocabulary
Synonyms
Neutral
Weak
Vocabulary
Antonyms
Usage
Context Usage
Business
Not used.
Academic
Used in medical and biomedical research literature.
Everyday
Extremely rare; only used by patients, caregivers, or when discussing specific medical conditions.
Technical
The primary context of use; standard term in clinical medicine, rheumatology, dermatology, and pathology.
Examples
By Part of Speech
adjective
British English
- sclerodermatous (rare technical adjective)
- The biopsy showed sclerodermatous changes.
American English
- sclerodermatous (rare technical adjective)
- The presentation was consistent with a sclerodermatous disorder.
Examples
By CEFR Level
- Scleroderma is a rare disease that hardens the skin.
- The doctor explained what scleroderma is.
- Localised scleroderma mainly affects the skin, whereas systemic scleroderma can involve internal organs.
- Diagnosing scleroderma often requires blood tests and a skin biopsy.
- The aetiology of scleroderma remains unclear, though it is believed to involve a complex interplay of autoimmune, genetic, and environmental factors.
- Current therapeutic strategies for systemic scleroderma focus on immunosuppression and managing specific organ-based complications.
Learning
Memory Aids
Mnemonic
Think: 'Sclero-' (hardening) + '-derma' (skin). A disease that hardens the skin.
Conceptual Metaphor
Disease as an invader (e.g., 'the disease attacks the connective tissue').
Watch out
Common Pitfalls
Translation Traps (for Russian speakers)
- Avoid direct calques like *склеродерма* without context; the standard medical term is 'склеродермия'.
- Do not confuse with 'склероз' (sclerosis), which is a broader term for hardening of tissue.
Common Mistakes
- Mispronouncing it as /sklero'dɜːmə/ (misplacing primary stress).
- Using it as an adjective (e.g., 'scleroderma skin' is less standard than 'sclerotic skin' or 'skin affected by scleroderma').
Practice
Quiz
Which body systems are primarily affected in systemic scleroderma?
FAQ
Frequently Asked Questions
No, scleroderma is an autoimmune disease and is not contagious.
Localised scleroderma typically affects only the skin and underlying tissues. Systemic scleroderma (systemic sclerosis) involves the skin and can affect blood vessels and internal organs like the heart, lungs, and kidneys.
There is currently no cure for scleroderma, but treatments are available to manage symptoms, slow progression, and prevent complications.
Scleroderma is more common in women than men and typically develops between the ages of 30 and 50. The exact cause is unknown.